New Cross Hospital is a hospital in the Heath Town district of Wolverhampton, West Midlands, England. It is located to the east of the city centre in Wednesfield and is managed by the Royal Wolverhampton NHS Trust.

During the past decade, New Cross Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 32 clinical trials were completed, i.e. on average, 51.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 18 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Cross Hospital" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Janssen Research & Development, LLC" with 10 trials sponsored, "Celgene" with 6 trials sponsored, "Institute of Cancer Research, United Kingdom" with 6 trials sponsored and "Shire" with 6 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Cross Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator and "British Heart Foundation" with 2 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "New Cross Hospital" are "Multiple Myeloma" (10 trials), "Breast Cancer" (9 trials), "Lymphoma" (7 trials), "Crohn's Disease" (6 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "New Cross Hospital" in a lesser frequency.

Most popular intervention types in "New Cross Hospital" are "Drug" (96 trials), "Procedure" (22 trials), "Other" (17 trials), "Radiation" (13 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Dexamethasone" (8 trials), "radiation therapy" (7 trials), "Rituximab" (6 trials) and "cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "New Cross Hospital" are 114 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "New Cross Hospital". undefined are not yet recruiting, 20 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in New Cross Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in New Cross Hospital, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".